814 related articles for article (PubMed ID: 21742216)
1. Surfactant therapy for acute lung injury and acute respiratory distress syndrome.
Raghavendran K; Willson D; Notter RH
Crit Care Clin; 2011 Jul; 27(3):525-59. PubMed ID: 21742216
[TBL] [Abstract][Full Text] [Related]
2. Surfactant for pediatric acute lung injury.
Willson DF; Chess PR; Notter RH
Pediatr Clin North Am; 2008 Jun; 55(3):545-75, ix. PubMed ID: 18501754
[TBL] [Abstract][Full Text] [Related]
3. Computed tomography assessment of exogenous surfactant-induced lung reaeration in patients with acute lung injury.
Lu Q; Zhang M; Girardi C; Bouhemad B; Kesecioglu J; Rouby JJ
Crit Care; 2010; 14(4):R135. PubMed ID: 20633284
[TBL] [Abstract][Full Text] [Related]
4. The future of exogenous surfactant therapy.
Willson DF; Notter RH
Respir Care; 2011 Sep; 56(9):1369-86; discussion 1386-8. PubMed ID: 21944686
[TBL] [Abstract][Full Text] [Related]
5. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
Wirbelauer J; Speer CP
J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
[TBL] [Abstract][Full Text] [Related]
6. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome.
Playfor SD; Nootigattu VK
Curr Drug Saf; 2006 May; 1(2):159-68. PubMed ID: 18690927
[TBL] [Abstract][Full Text] [Related]
7. Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?
Dushianthan A; Cusack R; Goss V; Postle AD; Grocott MP
Crit Care; 2012 Nov; 16(6):238. PubMed ID: 23171712
[TBL] [Abstract][Full Text] [Related]
8. A shared protocol for porcine surfactant use in pediatric acute respiratory distress syndrome: a feasibility study.
Wolfler A; Piastra M; Amigoni A; Santuz P; Gitto E; Rossetti E; Tinelli C; Montani C; Savron F; Pizzi S; D'amato L; Mondardini MC; Conti G; De Silvestri A
BMC Pediatr; 2019 Jun; 19(1):203. PubMed ID: 31215483
[TBL] [Abstract][Full Text] [Related]
9. Pediatric calfactant in acute respiratory distress syndrome trial.
Willson DF; Thomas NJ; Tamburro R; Truemper E; Truwit J; Conaway M; Traul C; Egan EE;
Pediatr Crit Care Med; 2013 Sep; 14(7):657-65. PubMed ID: 23846250
[TBL] [Abstract][Full Text] [Related]
10. Advances with surfactant.
Turell DC
Emerg Med Clin North Am; 2008 Nov; 26(4):921-8, viii. PubMed ID: 19059091
[TBL] [Abstract][Full Text] [Related]
11. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial.
Willson DF; Thomas NJ; Markovitz BP; Bauman LA; DiCarlo JV; Pon S; Jacobs BR; Jefferson LS; Conaway MR; Egan EA;
JAMA; 2005 Jan; 293(4):470-6. PubMed ID: 15671432
[TBL] [Abstract][Full Text] [Related]
12. Surfactant use for neonatal lung injury: beyond respiratory distress syndrome.
Finer NN
Paediatr Respir Rev; 2004; 5 Suppl A():S289-97. PubMed ID: 14980286
[TBL] [Abstract][Full Text] [Related]
13. Surfactant replacement therapy.
Stevens TP; Sinkin RA
Chest; 2007 May; 131(5):1577-82. PubMed ID: 17494810
[TBL] [Abstract][Full Text] [Related]
14. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
[TBL] [Abstract][Full Text] [Related]
15. Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury.
Cattel F; Giordano S; Bertiond C; Lupia T; Corcione S; Scaldaferri M; Angelone L; De Rosa FG
Respir Physiol Neurobiol; 2021 Jun; 288():103645. PubMed ID: 33657448
[TBL] [Abstract][Full Text] [Related]
16. Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.
Creery WD; Hashmi A; Hutchison JS; Singh RN
Pediatr Pulmonol; 1997 Nov; 24(5):370-3. PubMed ID: 9407571
[TBL] [Abstract][Full Text] [Related]
17. [Preterm and term infants with acute respiratory distress syndrome (ARDS): what is the role of surfactant substitution?].
Wirbelauer J; Thomas W; Speer CP
Z Geburtshilfe Neonatol; 2009 Apr; 213(2):33-41. PubMed ID: 19319791
[TBL] [Abstract][Full Text] [Related]
18. Exogenous surfactant therapy in acute lung injury/acute respiratory distress syndrome: the need for a revised paradigm approach.
Dushianthan A; Cusack R; Grocott M; Postle A
J Cardiothorac Vasc Anesth; 2012 Oct; 26(5):e50. PubMed ID: 22520116
[No Abstract] [Full Text] [Related]
19. Polymer Lung Surfactants Attenuate Direct Lung Injury in Mice.
Fesenmeier DJ; Suresh MV; Kim S; Park S; Raghavendran K; Won YY
ACS Biomater Sci Eng; 2023 May; 9(5):2716-2730. PubMed ID: 37079432
[TBL] [Abstract][Full Text] [Related]
20. Surfactant therapy for maternal blood aspiration: an unusual cause of neonatal respiratory distress syndrome.
Celik IH; Demirel G; Canpolat FE; Erdeve O; Dilmen U
Indian J Pediatr; 2012 Oct; 79(10):1358-9. PubMed ID: 22120615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
